Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Comprehensive Cholesterol Tests Provides Clues for Metabolic Abnormality

By LabMedica International staff writers
Posted on 20 Sep 2010
A detailed lipid profile is helping physicians to diagnose Polycystic Ovarian Syndrome (PCOS), the number one cause of female infertility. More...


The comprehensive cholesterol panel known as the Vertical Auto Profile (VAP) measures 15 separate components of blood cholesterol and can identify a far greater number of lipid abnormalities than standard low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol, and triglycerides.

The VAP test is the only cholesterol test to identify markers for Metabolic Syndrome, a precursor for diabetes. The VAP extended lipid test was developed by Atherotech Diagnostics, (Birmingham, AL, USA) and can report 22 blood "cholesterol” components including accurate measurement of nonfasting direct LDL and all the lipoprotein subclasses.

PCOS increases the risk of heart disease, insulin resistance, diabetes and certain cancers. It is also the most common metabolic abnormality in women of childbearing age, affecting 5-10 million women nationwide. While there is no single test for diagnosing the illness, the detailed cholesterol profile is proving useful. The four major symptoms of PCOS are irregular periods, weight gain, high testosterone levels, and metabolic disorders, including abnormal cholesterol levels. Results have shown a correlation between patients who have PCOS and high levels of total cholesterol and triglycerides, but low levels of high-density lipoprotein 2, a highly protective subclass of HDL.

Steven Foley, M.D., a physician who specializes in PCOS, said, "It is the most accurate and easiest method to evaluate my female patients for elevated cholesterol as well as polycystic ovarian syndrome. It is particularly valuable when developing a treatment plan for women and also helps to monitor response to treatment."

Related Links:

Atherotech




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.